Clinical Trials Browser

Phase 1/2 × Uterine Cervical Neoplasms × toripalimab × Clear all

NCT04651127 2026-03-10

Anti-PD-1 Antibody Combined With Histone Deacetylase Inhibitor in Patients With Advanced Cervical Cancer

Phase 1/2 Terminated

5 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT06093438 2025-03-11

Induction Toripalimab and Chemotherapy in Locally Advanced Cervical Cancer

Phase 1/2 Recruiting

20 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT05955105 2024-05-21

A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies

Phase 1/2 Recruiting

200 enrolled

BreastDermatologicGynecologicHead & NeckSarcomaThoracic

Nasopharyngeal Carcinoma, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Head and Neck Neoplasms, Melanoma, Ovarian Neoplasms, Sarcoma, Endometrial Neoplasms, Triple Negative Breast Neoplasms

NCT04368273 2020-04-29

CCRT+PD-1

Phase 1/2 Unknown

30 enrolled

Gynecologic

Uterine Cervical Neoplasms